CN102526446A - Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same - Google Patents
Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same Download PDFInfo
- Publication number
- CN102526446A CN102526446A CN2012100095356A CN201210009535A CN102526446A CN 102526446 A CN102526446 A CN 102526446A CN 2012100095356 A CN2012100095356 A CN 2012100095356A CN 201210009535 A CN201210009535 A CN 201210009535A CN 102526446 A CN102526446 A CN 102526446A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart disease
- medicated wine
- medicine composition
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 149
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 96
- 235000014101 wine Nutrition 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 41
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims abstract description 47
- 241000736148 Styrax Species 0.000 claims abstract description 47
- 239000004870 Styrax Substances 0.000 claims abstract description 47
- 235000000126 Styrax benzoin Nutrition 0.000 claims abstract description 47
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 28
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000004806 packaging method and process Methods 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 72
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 48
- 229940079593 drug Drugs 0.000 claims description 42
- 238000005303 weighing Methods 0.000 claims description 18
- 238000007654 immersion Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 28
- 208000019622 heart disease Diseases 0.000 abstract description 8
- 241000402754 Erythranthe moschata Species 0.000 abstract 5
- 239000000126 substance Substances 0.000 abstract 2
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 66
- 210000004369 blood Anatomy 0.000 description 63
- 210000002216 heart Anatomy 0.000 description 41
- 230000001737 promoting effect Effects 0.000 description 32
- 208000002193 Pain Diseases 0.000 description 27
- 230000017531 blood circulation Effects 0.000 description 27
- 208000024891 symptom Diseases 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 230000003203 everyday effect Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 210000000038 chest Anatomy 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 206010002383 Angina Pectoris Diseases 0.000 description 8
- 210000003141 lower extremity Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 8
- 229910052753 mercury Inorganic materials 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 206010003119 arrhythmia Diseases 0.000 description 7
- 230000006793 arrhythmia Effects 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 230000036770 blood supply Effects 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 239000006187 pill Substances 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000002349 favourable effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010011703 Cyanosis Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 238000002601 radiography Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000015096 spirit Nutrition 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008899 fufang danshen Substances 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241001314440 Triphora trianthophoros Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000009465 diaoxinxuekang Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000009982 suxiao jiuxinwan Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Abstract
The invention discloses a traditional Chinese medicine composition for treating coronary heart disease and a method for preparing medicated wine by utilizing the same. The traditional Chinese medicine composition disclosed by the invention mainly comprises the following bulk pharmaceutical chemicals in parts by weight: 200-250 parts of radix panacis quinquefolii, 200-250 parts of panax notoginseng, 18-25 parts of saffron crocus, 150-180 parts of radix salviae miltiorrhizae, 4-6 parts of musk, 25-35 parts of styrax, 80-120 parts of ramulus cinnamomi, 180-200 parts of allium macrostemon, 80-120 parts of pericarpium trichosanthis and 2,300-2,700 parts of white spirit. The method comprises the following steps of: soaking the bulk pharmaceutical chemicals except for musk and styrax into the weighed white spirit; then filtering to obtain a liquid medicine; dissolving the musk and styrax into the white spirit respectively to obtain musk medicated wine and styrax medicated wine; pouring the musk medicated wine and styrax medicated wine into the liquid medicine, and mixing uniformly; and sterilizing, disinfecting and sub-packaging to obtain the medicated wine for treating coronary heart disease disclosed by the invention. According to the invention, the prepared medicated wine has an obvious curative effect in treating coronary heart disease, the cure rate can reach over 80%, and the effective rate is over 90%; and the medicated wine also has a better effect in treating other heart diseases.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of method for preparing of treating the Chinese medicine composition and the medicated wine thereof of coronary heart disease.
Background technology
It is atherosis that coronary heart disease is meant that the coronary artery of directly giving heart blood supply occurs, and tube chamber is narrowed down, and hinders the atherosclerosis of aorta property heart disease that blood flow causes through deficiency myocardial blood supply occurring.The coronary heart disease pilosity is born in the old people, and that the common sympton of coronary heart disease has is uncomfortable in chest, breathe hard, have palpitation, arrhythmia and angina pectoris etc.Coronary heart disease does not have manifest symptom in early days, catch cold suddenly, run fast, the amount of labour is big, air pressure is low, run into strongsituation, sense of depression is arranged, during excited situation, occur uncomfortable in chest, symptom such as breathe hard easily.Coronary heart disease comprises symptoms such as angina pectoris, myocardial infarction, myocardiosclerosis, arrhythmia, and it is higher to suffer from this patient death rate.According to statistics, the patient of disease is died from the whole world in 2008, and its heart disease accounts for the first place.
Chronic coronary heart disease is common ailment of middle-aged and old and frequently-occurring disease, course of disease delay, and symptom is complicated, and obstinate difficult, easy relapse is treated thorny.At present, the method for treating chronic coronary heart disease is more, mainly adopts Drug therapy, and mainly is western medicine, and the effect of western medicine coronary heart disease is not satisfactory, cures the symptoms, not the disease.Like Western medicine " hypertension pill " commonly used, its total effective rate only has 86%, and cure rate is just lower.Adopt western medicine many, improve myocardial oxygen delivery and reduce myocardial oxygen consumption, thereby alleviate state of an illness symptom to adopt the medicine approach of coronary dilating and decreased heart rate.Facts have proved, though this type medicine can be alleviated disease to a certain extent, exist impairment of YIN all the time, consumption gas, difficult Da Zhiben is sorry.Normally the state of an illness is alleviated during medication, in case the drug withdrawal state of an illness increase the weight of again, if inappropriate medication also possibly failed to respond to any medical treatment even increased the weight of disease.Not only danger coefficient is big, expense is high, less patient suffering to adopt operative treatment coronary heart disease, and cure rate is lower.How curing this pertinacious disease of chronic coronary heart disease, is countries in the world health organization and the heat subject that relevant scientific research personnel concentrates on studies, and expects that effective in cure significant medicine comes out early, removes the misery of numerous patients with coronary heart disease, brings benefit to the mankind.
At present; Chinese medicine about treatment coronary heart disease also has relevant patent documentation report; For example: 1, application number is that 200610037680.X, name are called the patent of invention of " Chinese medicine of treatment coronary heart disease "; The disclosed Chinese medicine of this patent is to be material medicine with the Radix Aucklandiae, the Radix Paeoniae Alba, Radix Ginseng, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Rhizoma Cyperi, Radix Aristolochiae, Radix Salviae Miltiorrhizae, Poria, Radix Scrophulariae, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Radix Curcumae, Radix Glycyrrhizae, mixes according to rational proportion to add proper honey and process Chinese medicine pill.2, application number is that " 200910067320.8 ", name are called the patent of invention of " medicine of treatment coronary heart disease "; More than ten kind of natural Chinese medicinal herb such as the disclosed choice of drug Semen Persicae of this patent, Radix Pseudostellariae, the Radix Astragali, Fructus Trichosanthis, the Rhizoma Pinelliae, Bulbus Allii Macrostemonis, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae, Fructus Amomi, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Herba Asari, Radix Notoginseng, Stigma Croci; Form through scientific and reasonable compatibility; Make its each efficacy of drugs synergism, reach the purpose of effective treatment coronary heart disease.3, application number is that " 200510082651.0 ", name are called the patent of invention of " a kind of medicine of treating coronary heart disease ", and the disclosed medicine of this patent is that feedstock production forms with Lignum Aquilariae Resinatum, Lignum Dalbergiae Odoriferae, Lignum Santali Albi, Rhizoma Corydalis, Fructus Piperis Longi, Olibanum, Radix Salviae Miltiorrhizae, Radix Curcumae, Semen Trichosanthis, Radix Notoginseng, succinum, Cinnabaris, Calculus Bovis, Borneolum Syntheticum and Benzoinum.Coronary heart disease can treated and effect a radical cure to this invention medicine, and other heart diseases are also had better curative effect, improved patient's life quality and the time greatly, and higher healing rehabilitation efficacy is arranged.
Summary of the invention
The technical problem that the present invention will solve provides a kind of method for preparing of treating the Chinese medicine composition and the medicated wine thereof of coronary heart disease.Utilize technical scheme of the present invention can prepare the medicated wine of treating coronary heart disease, the medicated wine treatment coronary heart disease of utilizing the present invention to prepare, it is evident in efficacy, and cure rate can reach more than 80%, and effective percentage reaches more than 90%; And other cardiopathic treatments also there is curative effect preferably.
In order to address the above problem, the technical scheme that the present invention adopts is:
The present invention provides a kind of Chinese medicine composition of treating coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
200～250 parts of Radix Panacis Quinquefoliis, 200～250 parts of Radix Notoginseng, 18～25 parts of Stigma Crocis, 150～180 parts of Radix Salviae Miltiorrhizaes, 4～6 parts in Moschus, 25～35 parts of Styrax, 80～120 parts of Ramulus Cinnamomi, 180～200 parts of Bulbus Allii Macrostemonis, 2300～2700 parts of 80～120 parts of Pericarpium Trichosanthiss and Chinese liquor.
According to the Chinese medicine composition of above-mentioned treatment coronary heart disease, said Chinese medicine composition mainly is made up of following crude drug:
200～220 parts of Radix Panacis Quinquefoliis, 200～220 parts of Radix Notoginseng, 19～22 parts of Stigma Crocis, 150～160 parts of Radix Salviae Miltiorrhizaes, 4～6 parts in Moschus, 28～32 parts of Styrax, 90～110 parts of Ramulus Cinnamomi, 190～200 parts of Bulbus Allii Macrostemonis, 2400～2600 parts of 90～110 parts of Pericarpium Trichosanthiss and Chinese liquor.
According to the Chinese medicine composition of above-mentioned treatment coronary heart disease, said Chinese medicine composition mainly is made up of following crude drug:
200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng, 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 30 parts of Styrax, 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and Chinese liquor.
According to the Chinese medicine composition of above-mentioned treatment coronary heart disease, the number of degrees of said Chinese liquor are 48～52 °.
According to the Chinese medicine composition of above-mentioned treatment coronary heart disease, said Chinese liquor is jowar wine, and its number of degrees are 48～52 °.
A kind of Chinese medicine composition that utilizes said treatment coronary heart disease prepares the method for medicated wine, and said method for preparing is:
A, at first the proportioning ratio according to the Chinese medicine composition of above-mentioned each said treatment coronary heart disease takes by weighing various crude drug;
B, being soaked in the Chinese liquor that takes by weighing except that Moschus, crude drug the Styrax of will taking by weighing were soaked 3 months, and sealed tightly, and stirred once in 15 days at every interval in immersion process, and it is tight to stir the back sealing, filters after the immersion, obtains medicinal liquid;
C, the crude drug Moschus that takes by weighing is pulverized, the Moschus after pulverizing progressively is dissolved in the Chinese liquor, obtain Moschus medicated wine after the dissolving;
D, the crude drug Styrax that takes by weighing is dissolved in the Chinese liquor, obtains Styrax medicated wine;
The Styrax medicated wine that e, the Moschus medicated wine that step c is obtained and steps d obtain is poured mix homogeneously in the medicinal liquid that step b obtains respectively into, and last sealed packaging gets final product.
Prepare the method for medicated wine according to the above-mentioned Chinese medicine composition that utilizes said treatment coronary heart disease, the Moschus after will pulverizing described in the step c progressively is dissolved in the Chinese liquor, wherein Moschus and Chinese liquor between the two the ratio of addition be the 1g Moschus: 180～220mL Chinese liquor.
The method for preparing medicated wine according to the above-mentioned Chinese medicine composition that utilizes said treatment coronary heart disease; Described in the steps d crude drug Styrax that takes by weighing is dissolved in the Chinese liquor, wherein Styrax and Chinese liquor between the two the ratio of addition be the 1g Styrax: 28～40mL Chinese liquor.
Medicated wine of the present invention is distributed into 250 milliliters every bottle; Medicated wine instructions of taking of the present invention: general patient, sooner or later respectively obey 5 milliliters every day; The heavy patient sooner or later can respectively obey 10 milliliters every day.
The course of treatment: 30 days is a course of treatment, general 2～3 courses of treatment.
The pharmacological action of the various crude drug of the present invention:
Radix Panacis Quinquefolii: cold in nature, acrid in the mouth, sweet, bitter; Go into the heart, lung, stomach, kidney, the large intestine Five Classics.Effect cures mainly: 1, QI invigorating tonifying YIN: these article have the merit of boosting qi and nourishing yin, often control deficiency of vital energy cough with asthma, internal injury is quenched one's thirst.2, clearing away heat and promoting production of body fluid: these article had both been walked edema caused by disorder of QI with sweet, cold property, went into the speciality of blood system again, the fire of the clear three warmers of tool, the merit of supplementing QI and nourishing YIN.Key medicine for supplementing QI for promoting the production of body fluid, replenishing YIN and removing heat.3, clearing away heat to stop bleeding: these article clearing away heat and promoting production of body fluid, the available hyperactivity of fire caused by deficiency of YIN of controlling, the blood network heat in blood of burning goes out blood disorder, cures mainly the lung-heat hemoptysis, intestinal heat is had blood in stool.
Radix Notoginseng: claim Radix Notoginseng again, warm in nature, sweet in the mouth, little hardship, nontoxic; Go into liver, stomach, large intestine three warps.Effect cures mainly: 1, hemostasis dissipating blood stasis: the kind hemostasis of these article dissipating blood stasis, existing using always controlled blood disorder, like cards such as metrorrhagia, puerperal blood faints, retention of lochia, traumatic hemorrhage.2, promoting blood circulation and detumescence: these article bitter in the mouth, warm in nature, it is logical that hardship is let out temperature, goes into then blood circulation promoting and blood stasis dispelling of blood system, and detumescence removes expands, with controlling traumatic injury, unknown carbuncle.3, eliminating stasis to stop pain: these article blood circulation promoting and blood stasis dispelling reducing swelling and alleviating pain, with controlling pain due to blood stasis, pounce on damage pain, cards such as carbuncle pain, the pain relieving effect is best.
Stigma Croci: property is flat, sweet in the mouth; Go into the heart, liver two warps.Effect cures mainly: 1, blood circulation promoting and blood stasis dispelling: this medicine color is red, goes into the conscience warp, and sweet in the mouth is cold, enriches blood and invigorates blood circulation, blood stasis dispelling easing the affected liver, the merit of removing pathogenic heat from blood and toxic substance from the body.Be usually used in married woman's amenorrhea, postnatal blood stasis stomachache, treating swelling and pain by traumatic injury, typhoid fever multiple disease such as go mad.2, dispersing stagnation and relieving accumulation of pathogens: the Stigma Croci nature and flavor are sweet to be increased, and goes into liver heart channel, is good at blood circulation promoting and blood stasis dispelling, the dispersing the stagnated live-QI to relieve the stagnation of QI regulating QI to relieve pain.Be usually used in the pent-up of being worried, the chest and diaphragm feeling of fullness, palpitation with fear is in a trance, diseases such as breast side of body feeling of distension and oppression.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, liver,kidney,spleen four warps.Effect cures mainly: the accent blood of 1, invigorating blood circulation: the Radix Salviae Miltiorrhizae red complexion, going into heart channel, bitter in the mouth can drop-down.So heart governing blood and vessels, blood stored in the liver are can promoting blood circulation to restore menstrual flow and transfer blood.These article can cure mainly menoxenia, amenorrhea due to stagnation of blood, metrorrhagia and metrostaxis, and disharmony of Chong and Conception Channels and frequent fetal movement, blood is more than down.Puerperal congestion, cards such as lochiorrhea.Its cold nature of Yin Ben article is so stagnant person should it with heat in blood.The real key medicine of blood of transferring for invigorating blood circulation.2, stasis-dispelling and pain-killing: Radix Salviae Miltiorrhizae is the key medicine of blood system, goes into the heart, liver, kidney channel.If that the heart is become homeless is main, the liver blood meridians lose in catharsis, suffer from a deficiency of the kidney and by cold-damp the visitor, and the coagulation of QI-blood that causes; The strong foot numbness of spinal column, the card of pain, logical the loosing of these article ability removing blood stasis with potent drugs, the promoting the circulation of blood of invigorating blood circulation, congestion leads to and removes bitterly certainly.Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, interiorization internal organs to the stasis of blood stagnate, but outer qualcomm meridian and sharp joint, so these article can cure mainly dysmenorrhea; Puerperal the stasis of blood stomachache that stagnates, trusted subordinate's pain ， lumps in the chest and abdomen and the vexed obturation of wrist; Hernia attack dash and end do free, foot knee joint numbness fistula and pain, or the joint that congestion is blocked is attacked congestion pain such as pain.Can disappear mass in the abdomen and removing mass gathers, but migratory arthralgia work and strong waist knee joint again.It proves effective originally, all comes from blood circulation promoting and blood stasis dispelling, the merit of the logical operation of a surname.3, removing heat from blood detumescence: Radix Salviae Miltiorrhizae is gone into the heart, liver two warps, and its property is cold partially, so can removing heat from blood.But these article with promoting blood circulation and cooling blood be good at, dissipating blood stasis again.4, nourishing blood to tranquillize the mind: heart governing blood and vessels, main mind.The event of these article can reinforcing the heart be decided will, nourishing blood to tranquillize the mind, and relieving restlessness can clear away heart-fire again.Both can treat the forgetful palpitation with a distress feeling due to the deficiency of heart-blood, the card of palpitation with fear uneasiness, and can treat calentura again and hinder and seek the card of dysphoria and insomnia.5, blood yiqi: the Radix Salviae Miltiorrhizae red complexion is gone into blood, can invigorate blood circulation, and can enrich blood again.These article reinforcement and elimination in combination is so there is the title of Zhiyang medicine in the moon.
Moschus: warm in nature, acrid in the mouth, go into the heart, spleen, liver three warps.Effect cures mainly: the refreshment of 1, having one's ideas straightened out: the hot perfume (or spice) of these article is walked to scurry, and can go into the heart to have one's ideas straightened out, to exorcise evil spirits to open and close, and coma is returned to normal, and the stronger logical power of closing of having one's ideas straightened out is arranged, and is refreshment analepsia key medicine.Excess syndrome of stroke such as all apoplexy, syncope due to accumulation of phlegm, infantile convulsion, unconsciousness due to high fever, see locked mouth arranged, hold, arteries and veins is strong etc., an all available article are with emergency.2, the collateral dredging of passing through: these article are hot to loose that temperature is logical, fragrance is walked to scurry, and 12 warps that can pass through have the merit of the collateral dredging of passing through, and can be used for the cards such as amenorrhea ， mass in the abdomen due to the blockage of meridian.3, promoting blood circulation and stopping pain: the hot temperature of loosing of these article is logical, both adjustable mechanism of qi the meridian dredging, can stagnating of promoting the circulation of blood branching tie with dissipating blood stasis again, has the merit of blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain.To swollen ulcer drug, diseases such as traumatic injury, it is knowingly followed the example of a wrongdoer for significantly, is one of surgery good medicine.4, the tire of hastening parturition down: its fragrant virtue of these article is strong, kindly can walk to scurry and the key of being open to the custom; 12 warps that in addition can pass through again, the merit of tool promoting the circulation of QI to relieve pain, blood circulation promoting and dispersing pathogen accumulation; Render a service so expedite the emergence of down tire, to married woman's difficult labour, cards such as retention of placenta, retention of dead fetus all can be used.5, parasite killing detoxifcation: the warm little hardship of these article suffering, fragrance virtue are strong.Hot fragrant anthelmintic, uninteresting parasite killing so these article are for oral administration, have the power of the Enterozoa of killing; Again because of these article can be open to the custom key, promoting flow of QI and blood, the eliminating stagnation of stimulating the menstrual flow, so the also merit of prodigiosin system parasites poison.
Styrax: warm in nature, acrid in the mouth, go into lung, liver two warps.Effect cures mainly: 1, dissipating depression and eliminating phlegm: these article acrid in the mouth, warm in nature, the gas that gathers all perfume forms, so the merit of tool dissipating depression and eliminating phlegm.Commonly used controlling because of accumulation of phlegm causes convulsive diseases, the disease of fainting, epilepsy are sick.2, ward off dirty parasite killing: the gas that these article gather all perfume forms, and can keep away all not just gas, but and parasite killing.Pyrexial malaria, scabies, the rash miliaria controlled commonly used.3, circulation of qi promoting promoting the circulation of blood: these article acrid in the mouth is warm in nature, and the property that tool fragrance is walked to scurry is had the length of warming the meridian and promoting blood circulation again, so can be used for all diseases of qi depression to blood stasis.QI-mass mass formed by blood stasis, breast abdomen cold type of pain, QI rising in reverse order wrist pain, the chilblain controlled commonly used.4, inducing diuresis to remove edema: these article acrid in the mouth, warm in nature, the merit of tool inducing diuresis to remove edema is so can be used for the card of watery distension.
Ramulus Cinnamomi: warm in nature, acrid in the mouth, sweet; Go into bladder, the heart, lung three warps.Effect cures mainly: 1, expelling pathogenic factors from muscles by diaphoresis: these article gas Bao Shengfu, and upwards outwards, reach battalion thoroughly and defend, expelling pathogenic factors from muscles by diaphoresis, the wind dispelling cold expelling is for separating exterior syndrome due to wind-cold article commonly used outward.Commonly used control the wind and cold exterior deficiency, Solar watch is strongly fragrant, exterior cold and interior heat.2, warm promoting blood circulation: the hot temperature of these article, the yang-energy of temperature the whole body, the blood vessels on the logical whole body.Interior warm internal organs, the exterior cold of loosing outward is warm promoting blood circulation key medicine.Commonly used control that blood deficiency is caught cold, cold uterus, the arthralgia due to stagnation of blood of stagnating.3, warming YANG activating QI: the hot temperature of these article, rouse oneself yang-energy, the exploitation space between skin and muscles, regulating fluid apssage helps the sun of three warmers, the article that must use for phlegm retention water.Commonly used control temperature reduce phlegm drink, warming YANG to promote diuresis, sun water-retention.4, warm smart eliminating impediment: these article temperature three-way meridian, can hotly loose expelling wind and dampness outward; Nei Kewentong, dispersing cold for relieving pain more can be led all medicines of wind-damp dispelling, and the effect of killing three birds with one stone is received by through sick institute.5, the logical breast sun of temperature: these article suffering can be passed through, and temperature can be supporing yang, is warm breast sun good merchantable brand.The thoracic obstruction, the cardiopalmus controlled commonly used.6, warming spleen and stomach for dispelling cold: these article Xin Ganwen, hot can circulation of qi promoting, temperature can cold expelling, sweet can tonify deficiency, the strong fortune of middle-jiao yang, function of the spleen and stomach the cold-evil remove, pain is ended.7, pass through xiaozheng: This product warm-blood, and bring drugs directly to patients, slow xiaozheng blocks, and even more significant effect.8, making the adverse-rising QI downwards: the sun of Ramulus Cinnamomi temperature heart kidney, the gas that precipitation is cold has the merit of making the adverse-rising QI downwards.
Bulbus Allii Macrostemonis: warm in nature, acrid in the mouth, hardship; Nontoxic; Go into the heart, liver, lung, stomach four warps.Effect cures mainly: the chest stuffiness relieving of 1, regulating the flow of vital energy: these article acrid in the mouth, and bitter, warm in nature, the hot hardship of loosing is fallen, and Wen Tongneng mends, and goes into lung stomach warp again, is apt to open the numbness cold expelling, and warming middle-JIAO activates yang, and is usually used in thoracic obstruction twinge, and the wrist painful abdominal mass is uncomfortable, the QI rising in reverse order or thoracic obstruction persons such as hypochondriac pain.The cards such as obstruction of qi in the chest and cardialgia, gastral cavilty distending pain, depression of liver-QI of controlling commonly used.2, warming spleen and stomach for dispelling cold: the hot temperature of these article, go into lung, stomach two warps.Kind in the cold-evil of pulmonary, the gas of diarrhea Jiao Yangming is usually used in weighing behind cough and asthma, the cold-dysentery, controls the red white disease that waits of woman's leukorrhagia.3, the pain relieving of passing through.4, heat-clearing and toxic substances removing: these article bitter in the mouth, bitter ability heat-clearing and toxic substances removing is let out the fire dehumidifying, rises for scabies.
Pericarpium Trichosanthis: cold in nature, sweet in the mouth, go into lung, stomach two warps.Effect cures mainly: Qinghua heat-phlegm, promoting the circulation of QI the chest stuffiness relieving, moistening the lung and resolving phlegm.Use always and control phlegm-heat cough, pharyngalgia, chest pain is spitted blood, and epistaxis is quenched one's thirst, constipation, cards such as carbuncle pyogenic infections from tumour or sore.
Prescription of the present invention is reasonably combined according to the traditional Chinese medical science " monarch ", and the consumption science is selected for use the West to participate in the heart and gone into brain, strongly invigorating primordial QI, and the property of medicine is not dry, balance is monarch; Radix Notoginseng is to wait medicine on the blood circulation promoting and blood stasis dispelling, hemorrhage ending, and blood deficiency can be mended, and blood stasis can lead to and can live.Modern pharmacology is analyzed: blood vessel dilating, blood circulation promoting.It is blood circulation promoting and blood stasis dispelling that Stigma Croci is gone into heart channel, and going into blood system is the gas medicine in the blood.Modern pharmacology is analyzed: have thrombus dissolving, anticoagulant effect.Radix Salviae Miltiorrhizae (Herba Wedeliae Wallichii) is coronary artery dilator directly, alleviates the heart oxygen consumption, and Ramulus Cinnamomi is gone into heart channel, warming and activating heart-YANG.The traditional Chinese medical science thinks that the heart is that key is dirty, selects Moschus, Styrax for use, be open to the custom have one's ideas straightened out, scurrying property is strong, the fast strong messenger drug that is of the effect of regulating QI to relieve pain.Bulbus Allii Macrostemonis, Pericarpium Trichosanthis, logical heart-yang, open breast gas, regulating the flow of vital energy relieves the pain.With liquor for the materials, because wine has "Mizutani Piaohan" qi xue qi yang, OK drug fast and has a dilation of blood vessels.Prescription of the present invention is monarch with the Radix Panacis Quinquefolii, and Radix Notoginseng, Stigma Croci are minister, and Radix Salviae Miltiorrhizae, Bulbus Allii Macrostemonis, Pericarpium Trichosanthis, Ramulus Cinnamomi are assistant, and Moschus, Styrax are for making compatibility science, reasonable.Thereby play effects such as benefiting qi and removing blood stasis, coronary circulation-promoting pain-relieving, expander thrombolytic.Be applicable to coronary heart disease, myocardial infarction, angina pectoris, cardiopalmus, nervous, uncomfortable in chest, breathe hard, arrhythmia and high blood viscosity.
Positive beneficial effect of the present invention:
1, Chinese medicine composition of the present invention be applicable to coronary heart disease, myocardial infarction, angina pectoris, cardiopalmus, nervous, uncomfortable in chest, breathe hard, arrhythmia and high blood viscosity.Utilize the various coronary heart disease indications of traditional Chinese medicine composition for treating of the present invention, determined curative effect, convenient cheap, safe and reliable is a kind of method of approach proper treatment coronary heart disease.
2, utilize the various indications of traditional Chinese medicine composition for treating coronary heart disease of the present invention, it is evident in efficacy, and the treatment effective percentage reaches more than 90%, and cure rate reaches more than 80%.
3, the present invention's Chinese medicine and medicated wine thereof of treating coronary heart disease not only has significant curative effect to coronary heart disease, and other heart diseases are also had better therapeutic effect.
The indication of traditional Chinese medicine composition for treating of the present invention: coronary heart disease, myocardial infarction, cardiopalmus, breathe hard, card such as uncomfortable in chest, arrhythmia.
Medicated wine instructions of taking of the present invention: general patient, sooner or later respectively obey 5 milliliters every day; The heavy patient sooner or later can respectively obey 10 milliliters every day.
The course of treatment: 30 days is a course of treatment, general 2～3 courses of treatment.
The treatment principle of Drug therapy coronary heart disease of the present invention: coronary artery dilator, blood circulation promoting, blood circulation promoting and blood stasis dispelling, supplementing qi and invigorating vasculum, antithrombotic forms, and the thrombolytic anticoagulant alleviates myocardial oxygen consumption, and lightening heart load improves myocardial ischemia, effects such as arrhythmia.
The medicated wine that utilizes Chinese medicine composition of the present invention to prepare is treated the clinical data of various coronary heart disease indications:
In recent years, medicated wine of the present invention was through carrying out clinical treatment to 368 routine patients with coronary heart disease, and therapeutic effect has given sufficient confirmation.
This organizes 368 routine patients, all chooses at random, and the each patient all has electrocardiogram to make a definite diagnosis, in the treatment, treatment observes the treatment situation after have an electro-cardiogram.Hospitalization is arranged among the patient, out-patient treatment is arranged.Among the 368 routine patients, disease time the longest 30 surplus year, the shortest 2 months, male patient's 202 examples, female patient 166 examples, 38～85 years old age.Treat 296 examples of wherein fully recovering, 35 examples that are clearly better, 28 examples that take effect, invalid 9 examples through taking the medicated wine that the present invention treats coronary heart disease.Cure rate is up to 80%, and total effective rate reaches 97%.
Therapeutic Method: the patients with coronary heart disease different according to symptom, utilize the prescription of Chinese medicine composition of the present invention to allocate, and process medicated wine and take.
Medicated wine instructions of taking of the present invention: general patient, sooner or later respectively obey 5 milliliters every day; The heavy patient sooner or later can respectively obey 10 milliliters every day.
The course of treatment: 30 days is a course of treatment, general 2～3 courses of treatment.
The curative effect judgment criteria:
Make a definite diagnosis through electrocardiogram or heart radiography, Color Sonography, through the observe the curative effect of having an electro-cardiogram, treatment is after Electrocardioscopy in the therapeutic process, and the ST section transfers to normally or be normal basically.
Recovery from illness: patient's subjective symptoms disappears, and the ST section of having an electro-cardiogram is normal.
Take a turn for the better: patient's subjective symptoms takes a turn for the better, and the ST segment base of having an electro-cardiogram is originally normal.
Invalid: the conscious clinical symptoms of patient is not improved, and the ST section of having an electro-cardiogram is preceding the same with treatment.
Model case:
1, together so-and-so, woman 85 years old, people from Xinye County, Nanyang, this patient suffer from surplus the hypertension 30 year, often take reserpine, compound recipe Radix Raphani fiber crops sheet, erbanin, his fourth doubly, blood pressure often maintains 150/100 millimetres of mercury, is up to 200/140 millimetres of mercury.Often headache, dizzy, insomnia, hypomnesis, edema of pair of lower extremities; The eye often edema of getting up morning also, moving then pant, weak, 2000 in the Xinye County intracardiac section of hospital has an electro-cardiogram; Be diagnosed as hypertension, coronary heart disease, swollen amyocardia, hospitalization; Defeated fragrant red pin, clothes SUXIAO JIUXIN WAN, Radix Salviae Miltiorrhizae drop pill, Beijing verticil etc. are left hospital after sb.'s illness took a favorable turn.Increase the weight of because of the flu bronchitis in October, 2003,, find this patient's asthma, dizzy lip cyanosis, edema of pair of lower extremities, weak inappetence when seeing and treating patients, blood pressure 180/200 millimetres of mercury to Nanyang cardiovascular and cerebrovascular vessel hospital therapy; Pressure is vexed painful before the heart, arrhythmia, heart rate 54 times/minute; The ST section of having an electro-cardiogram is inverted, the serious blood supply insufficiency of heart lower wall, thin white fur of tongue; Irregularly intermittent and regularly intermittent pulse, disease belongs to: blood-vessel obstructive, doctor trained in Western medicine are diagnosed as coronary heart disease companion heart failure and merge upper respiratory tract infection.After come here to go to a doctor upon somebody's introduction, therapeutic scheme: infuse and take the medicated wine that the present invention treats coronary heart disease (instructions of taking of medicated wine is every day 2 times, each 10 milliliters; The raw material of the treatment coronary heart disease Chinese medicine composition that medicated wine of the present invention adopts consists of 200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng, 20 parts of Stigma Crocis; 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 30 parts of Styrax; 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and jowar wines (48 °); See embodiment 1 for details), take medicated wine of the present invention continuously after 1 week, this conditions of patients takes a favorable turn, and asthma disappears, and edema of pair of lower extremities is eliminated, and appetite heightens.Transfusion also continues to take medicated wine of the present invention (instructions of taking and medicinal liquor prescription are the same), take 1 course of treatment continuously after, have an electro-cardiogram, its ST section is clearly better, and takes 3 courses of treatment of medicated wine of the present invention continuously, above-mentioned symptom disappears, and has an electro-cardiogram inspection normally.
2, appoint so-and-so, man, 67 years old now; People from Nanyang, central hospital is diagnosed as coronary atherosclerotic heart disease to this patient through the Nanyang in March, 2003, suffers from surplus the hypertension 10 year; Blood pressure is through being everlasting between 180/110～150/90 millimetres of mercury, and all will take depressor every day.After come here to go to a doctor upon somebody's introduction, when this patient goes to a doctor yellowish complexion become thin, often dizzy, insomnia, upward downstairs palpitate quickly, pant; Uncomfortable in chest, general weakness, abdominal distention, appetite are poor; Look into heart rate 96 times/minute, restrain uneven, blood pressure 180/110 millimetres of mercury; Electrocardiogram is looked into the serious blood supply insufficiency of heart antetheca, and tongue fur BOHUANG, deficient pulse are unable.Western medicine diagnose is a coronary heart disease, Chinese medical discrimination, and heart deficiency of spleen-YANG, the blood vessels stasis of blood stagnates and gets along well, and controls suitable: warming YANG and invigorating QI, blood circulation promoting and blood stasis dispelling.According to patient's symptom, its therapeutic scheme is to take the medicated wine that the present invention treats coronary heart disease (raw material of the treatment coronary heart disease Chinese medicine composition that medicated wine of the present invention adopts consists of 205 parts of Radix Panacis Quinquefoliis, 205 parts of Radix Notoginseng; 21 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 4.5 parts in Moschus; 29 parts of Styrax; 90 parts of Ramulus Cinnamomi, 190 parts of Bulbus Allii Macrostemonis, 2450 parts of 90 parts of Pericarpium Trichosanthiss and jowar wines (48 °).See embodiment 4 for details), the instructions of taking of medicated wine is every day 2 times, each 10 milliliters, it is aid digestion to add the short stomach of Western medicine simultaneously.This patient takes medicated wine of the present invention after 1 week continuously, and above-mentioned symptom makes moderate progress, and takes medicated wine of the present invention continuously after 1 course of treatment, and symptom subtracts greatly, and spirit takes a turn for the better; Not dizzy, the heart is not flurried, heart rate 78 times/minute, and rule is neat, and appetite heightens; Blood pressure 140/90 millimetres of mercury, the ST section of having an electro-cardiogram is clearly better, and blood supply of cardiac muscle has much improvement, continues to take medicated wine of the present invention after 3 courses of treatment; Above-mentioned symptom disappears, and it is normal to have an electro-cardiogram, and follows up a case by regular visits to and does not have recurrence, recovery from illness in 3 years.
3, the king so-and-so, the woman, 68 years old now, live democracy street, Nanyang, the patient make a definite diagnosis coronary heart disease 5 years surplus, through how tame hospitalize, its therapeutic effect is not good.By the agency of comes here to go to a doctor, and first visit: this patient's yellowish complexion is thin and weak, and is moving then pant lip cyanosis; Often precordial fullness pain is radiated the left back back of the body, and heart radiography prompting arteria coronaria has 40-50 obstructed, blood pressure 150/110 millimetres of mercury; The patient is through informal dress depressor and FUFANG DANSHEN PIAN, ginkgo-leaf small pills, Moschus pills for curing heart disease, can only respite, and heart rate 52 times/minute, ventricular premature contraction takes place frequently; The time premature ventricular beat is arranged, the slight edema of two lower limb, diet is not good, irregularly intermittent and regularly intermittent pulse.The traditional Chinese medical science is thought deficiency of heart-YANG, blood-vessel obstructive.According to patient's symptom, the therapeutic scheme of taking is: (raw material of the treatment coronary heart disease Chinese medicine composition that medicated wine of the present invention adopts consists of 200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng to take the medicated wine that the present invention treats coronary heart disease; 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus; 30 parts of Styrax; 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and jowar wines (48 °); See embodiment 1 for details), instructions of taking is every day 2 times, each 10 milliliters, take 50 milliliters after, the patient feels that precordial fullness pain discomfort is clearly better, asthma is not felt in last the 2nd or three buildings, the crude drug composition of treatment coronary heart disease medicated wine is constant, continues to take.After the patient took 3 courses of treatment (course of treatment 1000 milliliters), edema of pair of lower extremities disappears, and was in high spirits, and the food drink heightens, the rhythm of the heart one minute 76 times, and premature ventricular beat disappears, and the rhythm of the heart is normal.Lip is cyanosis not, and the ST section of having an electro-cardiogram has been recovered normal value, and recovery from illness was not recurred after 1 year.
4, Zhao so-and-so, the man, 66 years old, 2007 in the Nanyang central hospital's radiography has two to reach 60-70 obstructed, the suggestion of Nanyang central hospital goes to Beijing to do to put the support operation, consider that the danger of operation is bigger, abandon operation.Come here to go to a doctor upon somebody's introduction, this patient suffers from surplus the hypertension 20 year, and blood fat is high; Eat the whole year such as depressor, FUFANG DANSHEN PIAN, DIAOXINXUE KANG, zhibituo etc., be in hospital twice every year, often edema of pair of lower extremities; The asthma of going upstairs is felt blue, and pareordia has a dull ache; Sometimes catch a cold concurrent asthma, cough, the trachea inflammation.After diagnosing, this patient belongs to heavy coronary heart disease, poor heart function, the serious blood supply insufficiency of heart.According to patient's various symptoms, the therapeutic scheme of taking is: (raw material of the treatment coronary heart disease Chinese medicine composition that medicated wine of the present invention adopts consists of 200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng to take the medicated wine that the present invention treats coronary heart disease; 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus; 30 parts of Styrax; 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and jowar wines (48 °); See embodiment 1 for details), instructions of taking is every day 2 times, each 10 milliliters.Take (one bottle 250 milliliters, 4 bottles 1 course of treatment) after 1 course of treatment, moving then asthma alleviates, and the food drink increases, and precordial fullness takes a favorable turn, and sleep has improvement, and it is obvious that it takes the medicated wine effect.Continue clothes medicated wine of the present invention according to original therapeutic scheme, take 3 courses of treatment continuously after, above-mentioned symptom is eliminated basically, 78 per minutes of heart rate of having an electro-cardiogram, the ST section is recovered normal value, rule is almost recovered together.
5, the king so-and-so, 72 years old, the woman, people from Xixia, Nanyang, 2000 through Nanyang central hospital's heart radiography confirm as coronary heart disease later stage companion heart failure.Be in hospital because of angina pectoris at that time, because of suffering from surplus the Inheritance property hypertension 20 year, blood pressure is 180/110 millimetres of mercury often before this, and depressor is constantly taken; The asthma of just often going upstairs before 5 years, an angry precordial fullness bitterly, edema of pair of lower extremities, lip cyanosis; Once because of the burst angina pectoris of feeling blue, anxious clothes nitroglycerin is able to alleviate, and be in hospital because of flu causes pneumonia continuous 3 year winter; Except that antiinflammatory, all fail the compound Salviae Miltiorrhizae pin, clothes Moschus pills for curing heart disease, the precious heart ball of Moschus, heart treasured; Obey a slice digoxin every night, be medicine commonly used, but be relief of symptoms.Introduce come here to go to a doctor through the people in March, 2009, and according to patient's symptom, the therapeutic scheme of taking is: (raw material of the treatment coronary heart disease Chinese medicine composition that medicated wine of the present invention adopts consists of 205 parts of Radix Panacis Quinquefoliis to take the medicated wine that the present invention treats coronary heart disease; 205 parts of Radix Notoginseng, 19 parts of Stigma Crocis, 155 parts of Radix Salviae Miltiorrhizaes; 4.5 parts in Moschus, 29 parts of Styrax, 95 parts of Ramulus Cinnamomi; 195 parts of Bulbus Allii Macrostemonis, 2500 parts of 95 parts of Pericarpium Trichosanthiss and jowar wines (48 °); See embodiment 8 for details), instructions of taking is every day 2 times, each 10 milliliters.Take 1 course of treatment, the state of an illness just take a favorable turn, and has then taken continuously 3 courses of treatment, and various symptoms all take a favorable turn, and are in high spirits, and two lower limb are also subsided a swelling, and go upstairs and do not breathe heavily basically, and angina pectoris is not once sent out, and the blood supply of having an electro-cardiogram is normal basically.Coronary heart disease is almost recovered, but still adheres to obeying 10 milliliters of medicated wine of the present invention every night, with prevention with consolidate curative effect.
Four, the specific embodiment:
Further specify the present invention below in conjunction with embodiment, but do not limit content of the present invention.
Embodiment 1:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng, 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 30 parts of Styrax, 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and the detailed step of this method for preparing is following:
A, at first the proportioning ratio according to the Chinese medicine composition of above-mentioned treatment coronary heart disease takes by weighing various crude drug;
B, being soaked in the Chinese liquor that takes by weighing except that Moschus, crude drug the Styrax of will taking by weighing were soaked 3 months, and sealed tightly, and stirred once in 15 days at every interval in immersion process, and it is tight to stir the back sealing, filters after the immersion, obtains medicinal liquid;
C, the crude drug Moschus that takes by weighing is pulverized, the Moschus after pulverizing progressively is dissolved in 1000 parts of Chinese liquor in addition, obtain Moschus medicated wine after the dissolving;
D, the crude drug Styrax that takes by weighing is dissolved in 1000 parts of Chinese liquor in addition, obtains Styrax medicated wine;
The Styrax medicated wine that e, the Moschus medicated wine that step c is obtained and steps d obtain is poured mix homogeneously in the medicinal liquid that step b obtains respectively into, and last sealed packaging gets final product.Every bottle of packing 250ml.
Embodiment 2: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
210 parts of Radix Panacis Quinquefoliis, 220 parts of Radix Notoginseng, 19 parts of Stigma Crocis, 160 parts of Radix Salviae Miltiorrhizaes, 4 parts in Moschus, 28 parts of Styrax, 90 parts of Ramulus Cinnamomi, 190 parts of Bulbus Allii Macrostemonis, 2550 parts of 90 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 3: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
220 parts of Radix Panacis Quinquefoliis, 210 parts of Radix Notoginseng, 22 parts of Stigma Crocis, 155 parts of Radix Salviae Miltiorrhizaes, 6 parts in Moschus, 32 parts of Styrax, 110 parts of Ramulus Cinnamomi, 195 parts of Bulbus Allii Macrostemonis, 2600 parts of 110 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 4: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
205 parts of Radix Panacis Quinquefoliis, 205 parts of Radix Notoginseng, 21 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 4.5 parts in Moschus, 29 parts of Styrax, 90 parts of Ramulus Cinnamomi, 190 parts of Bulbus Allii Macrostemonis, 2450 parts of 90 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 5: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
230 parts of Radix Panacis Quinquefoliis, 210 parts of Radix Notoginseng, 23 parts of Stigma Crocis, 170 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 25 parts of Styrax, 80 parts of Ramulus Cinnamomi, 180 parts of Bulbus Allii Macrostemonis, 2300 parts of 80 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 6: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
250 parts of Radix Panacis Quinquefoliis, 230 parts of Radix Notoginseng, 25 parts of Stigma Crocis, 180 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 35 parts of Styrax, 120 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2700 parts of 120 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 7: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng, 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 30 parts of Styrax, 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and Chinese liquor.
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 8: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
205 parts of Radix Panacis Quinquefoliis, 205 parts of Radix Notoginseng, 19 parts of Stigma Crocis, 155 parts of Radix Salviae Miltiorrhizaes, 4.5 parts in Moschus, 29 parts of Styrax, 95 parts of Ramulus Cinnamomi, 195 parts of Bulbus Allii Macrostemonis, 2500 parts of 95 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 9: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
220 parts of Radix Panacis Quinquefoliis, 210 parts of Radix Notoginseng, 22 parts of Stigma Crocis, 160 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 31 parts of Styrax, 105 parts of Ramulus Cinnamomi, 195 parts of Bulbus Allii Macrostemonis, 2600 parts of 105 parts of Pericarpium Trichosanthiss and Chinese liquor.
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Embodiment 10: basic identical with embodiment 1, difference is:
The present invention treats the Chinese medicine composition of coronary heart disease, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
205 parts of Radix Panacis Quinquefoliis, 205 parts of Radix Notoginseng, 21 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 4.5 parts in Moschus, 31 parts of Styrax, 95 parts of Ramulus Cinnamomi, 190 parts of Bulbus Allii Macrostemonis, 2480 parts of 90 parts of Pericarpium Trichosanthiss and jowar wines (48 °).
The present invention utilizes the Chinese medicine composition of above-mentioned treatment coronary heart disease to prepare the method for medicated wine, and method for preparing is with embodiment 1.
Claims (8)
1. a Chinese medicine composition of treating coronary heart disease is characterized in that, representes with weight portion, and said Chinese medicine composition mainly is made up of following crude drug:
200～250 parts of Radix Panacis Quinquefoliis, 200～250 parts of Radix Notoginseng, 18～25 parts of Stigma Crocis, 150～180 parts of Radix Salviae Miltiorrhizaes, 4～6 parts in Moschus, 25～35 parts of Styrax, 80～120 parts of Ramulus Cinnamomi, 180～200 parts of Bulbus Allii Macrostemonis, 2300～2700 parts of 80～120 parts of Pericarpium Trichosanthiss and Chinese liquor.
2. the Chinese medicine composition of treatment coronary heart disease according to claim 1 is characterized in that, said Chinese medicine composition mainly is made up of following crude drug:
200～220 parts of Radix Panacis Quinquefoliis, 200～220 parts of Radix Notoginseng, 19～22 parts of Stigma Crocis, 150～160 parts of Radix Salviae Miltiorrhizaes, 4～6 parts in Moschus, 28～32 parts of Styrax, 90～110 parts of Ramulus Cinnamomi, 190～200 parts of Bulbus Allii Macrostemonis, 2400～2600 parts of 90～110 parts of Pericarpium Trichosanthiss and Chinese liquor.
3. the Chinese medicine composition of treatment coronary heart disease according to claim 1 is characterized in that, said Chinese medicine composition mainly is made up of following crude drug:
200 parts of Radix Panacis Quinquefoliis, 200 parts of Radix Notoginseng, 20 parts of Stigma Crocis, 150 parts of Radix Salviae Miltiorrhizaes, 5 parts in Moschus, 30 parts of Styrax, 100 parts of Ramulus Cinnamomi, 200 parts of Bulbus Allii Macrostemonis, 2500 parts of 100 parts of Pericarpium Trichosanthiss and Chinese liquor.
4. the Chinese medicine composition of treatment coronary heart disease according to claim 1 is characterized in that: the number of degrees of said Chinese liquor are 48～52 °.
5. the Chinese medicine composition of treatment coronary heart disease according to claim 1 is characterized in that: said Chinese liquor is jowar wine, and its number of degrees are 48～52 °.
6. a Chinese medicine composition that utilizes said treatment coronary heart disease prepares the method for medicated wine, it is characterized in that said method for preparing is:
A, at first the proportioning ratio according to the Chinese medicine composition of each said treatment coronary heart disease of claim 1～3 takes by weighing various crude drug;
B, being soaked in the Chinese liquor that takes by weighing except that Moschus, crude drug the Styrax of will taking by weighing were soaked 3 months, and sealed tightly, and stirred once in 15 days at every interval in immersion process, and it is tight to stir the back sealing, filters after the immersion, obtains medicinal liquid;
C, the crude drug Moschus that takes by weighing is pulverized, the Moschus after pulverizing progressively is dissolved in the Chinese liquor in addition, obtain Moschus medicated wine after the dissolving;
D, the crude drug Styrax that takes by weighing is dissolved in the Chinese liquor in addition, obtains Styrax medicated wine;
The Styrax medicated wine that e, the Moschus medicated wine that step c is obtained and steps d obtain is poured mix homogeneously in the medicinal liquid that step b obtains respectively into, and last sealed packaging gets final product.
7. the Chinese medicine composition that utilizes said treatment coronary heart disease according to claim 6 prepares the method for medicated wine; It is characterized in that; Moschus after will pulverizing described in the step c progressively is dissolved in the Chinese liquor, wherein Moschus and Chinese liquor between the two the ratio of addition be the 1g Moschus: 180～220mL Chinese liquor.
8. the Chinese medicine composition that utilizes said treatment coronary heart disease according to claim 6 prepares the method for medicated wine; It is characterized in that; Described in the steps d crude drug Styrax that takes by weighing is dissolved in the Chinese liquor, wherein Styrax and Chinese liquor between the two the ratio of addition be the 1g Styrax: 28～40mL Chinese liquor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210009535 CN102526446B (en) | 2012-01-13 | 2012-01-13 | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210009535 CN102526446B (en) | 2012-01-13 | 2012-01-13 | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526446A true CN102526446A (en) | 2012-07-04 |
| CN102526446B CN102526446B (en) | 2013-11-06 |
Family
ID=46335266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210009535 Expired - Fee Related CN102526446B (en) | 2012-01-13 | 2012-01-13 | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526446B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906274A (en) * | 2015-06-09 | 2015-09-16 | 毛显青 | Traditional Chinese medicine for treating coronary heart disease |
| EP3020407A1 (en) * | 2013-07-11 | 2016-05-18 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| EP3020408A4 (en) * | 2013-07-11 | 2017-03-15 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| US10626077B2 (en) | 2013-08-29 | 2020-04-21 | Tasly Pharmaceutical Group Co., Ltd. | Salvianolic acid compound T, preparation method therefor, and use thereof |
| US11013694B2 (en) | 2013-07-11 | 2021-05-25 | Tasly Pharmaceutical Group Co., Ltd. | Formulation of a micro drop pill and the preparation method thereof |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088816A (en) * | 1993-01-01 | 1994-07-06 | 胡保华 | " Huxinxiangtong " powder medicine for treating heart diseases |
| CN1206595A (en) * | 1997-07-26 | 1999-02-03 | 王维广 | Thrombus dissolving Guiluchun |
| CN1539471A (en) * | 2003-11-01 | 2004-10-27 | 马绍格 | Prescription for treating cardiovascular disease and processing method |
| CN1853677A (en) * | 2005-04-25 | 2006-11-01 | 张树茂 | Chinese medicine for heart disease |
| CN1939483A (en) * | 2006-10-10 | 2007-04-04 | 张启栋 | Heart-nourishing capsules for treating coronary heart disease |
| CN101020028A (en) * | 2006-11-11 | 2007-08-22 | 刘光辉 | Chinese medicine for treating cardiac and cerebral vascular diseases |
| CN101439153A (en) * | 2007-11-20 | 2009-05-27 | 卢卫东 | Production of tonic wine |
-
2012
- 2012-01-13 CN CN 201210009535 patent/CN102526446B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088816A (en) * | 1993-01-01 | 1994-07-06 | 胡保华 | " Huxinxiangtong " powder medicine for treating heart diseases |
| CN1206595A (en) * | 1997-07-26 | 1999-02-03 | 王维广 | Thrombus dissolving Guiluchun |
| CN1539471A (en) * | 2003-11-01 | 2004-10-27 | 马绍格 | Prescription for treating cardiovascular disease and processing method |
| CN1853677A (en) * | 2005-04-25 | 2006-11-01 | 张树茂 | Chinese medicine for heart disease |
| CN1939483A (en) * | 2006-10-10 | 2007-04-04 | 张启栋 | Heart-nourishing capsules for treating coronary heart disease |
| CN101020028A (en) * | 2006-11-11 | 2007-08-22 | 刘光辉 | Chinese medicine for treating cardiac and cerebral vascular diseases |
| CN101439153A (en) * | 2007-11-20 | 2009-05-27 | 卢卫东 | Production of tonic wine |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3020407A1 (en) * | 2013-07-11 | 2016-05-18 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| EP3020408A4 (en) * | 2013-07-11 | 2017-03-15 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| EP3020407A4 (en) * | 2013-07-11 | 2017-05-03 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| AU2014289766B2 (en) * | 2013-07-11 | 2019-03-14 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
| US11013694B2 (en) | 2013-07-11 | 2021-05-25 | Tasly Pharmaceutical Group Co., Ltd. | Formulation of a micro drop pill and the preparation method thereof |
| USRE49035E1 (en) | 2013-07-11 | 2022-04-19 | Tasly Pharmaceutical Group Co., Ltd. | Traditional Chinese medicine composition, and preparation and application thereof |
| USRE49050E1 (en) | 2013-07-11 | 2022-04-26 | Tasly Pharmaceutical Group Co., Ltd. | Traditional Chinese medicine composition, and preparation and application thereof |
| US10626077B2 (en) | 2013-08-29 | 2020-04-21 | Tasly Pharmaceutical Group Co., Ltd. | Salvianolic acid compound T, preparation method therefor, and use thereof |
| CN104906274A (en) * | 2015-06-09 | 2015-09-16 | 毛显青 | Traditional Chinese medicine for treating coronary heart disease |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526446B (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178912B (en) | Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof | |
| CN102743738A (en) | External use navel spreading sparadrap for treating gastrointestinal dysfunction | |
| CN102526446B (en) | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN103977358A (en) | Oral traditional Chinese medicine for lowering lipid and protecting liver | |
| CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
| CN102755626A (en) | Traditional Chinese medicine combination for treating sinus sick syndrome and preparation method | |
| CN103536849B (en) | Medicine for the treatment of pulmonary infarction and preparation method thereof | |
| CN102274482A (en) | Chinese medicinal preparation for treating diabetes | |
| CN102188670B (en) | Medicament for treating extrauterine pregnancy | |
| CN104056128A (en) | Formula of traditional Chinese medicine for treating ulcerative colitis | |
| CN102038889B (en) | Traditional Chinese medicament for treating rheumatic heart disease | |
| CN102091163B (en) | Chinese medicine composition for treating diabetic heart disease | |
| CN105749172A (en) | Medicament for treating gastric calculus and preparation thereof | |
| CN105362914A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN101559205A (en) | Traditional Chinese medicine composition for curing chronic gastritis | |
| CN104800553A (en) | Traditional Chinese medicine composition for treating climacteric insomnia and preparation method of traditional Chinese medicine composition | |
| CN104398774A (en) | Traditional Chinese drug for treating diabetic peripheral neuropathy | |
| CN104645063A (en) | Pills for treating hyperplasia of mammary glands and preparation method thereof | |
| CN105687961A (en) | Preparation method of granule for treating coronary artery atherosclerosis | |
| CN105343298B (en) | A kind of navel paster and preparation method thereof for treating chronic constipation | |
| CN104056173A (en) | Traditional Chinese medicine composition for treating qi and blood deficiency of pregnant women in gestation period | |
| CN102716449A (en) | Chinese patent drug and traditional Chinese medicine decoction capable of treating excessive-cold type stomachache effectively | |
| CN102626485A (en) | Pure Chinese medicine preparation for treating hypertension | |
| CN105435175A (en) | Traditional Chinese medicine preparation used for treating postpartum abdominal pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |